Atea Pharmaceuticals, Inc. (AVIR) has 8 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: June 23, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| June 23, 2026 filed June 18, 2026 | BERGER FRANKLIN M Director | $0 | 123,600 | +365% | No | |
|
|
||||||
| June 23, 2026 filed June 18, 2026 | Lucidi Bruno Director | $0 | 123,600 | +365% | No | |
|
|
||||||
| June 23, 2026 filed June 18, 2026 | DUNCAN BARBARA GAYLE Director | $0 | 123,600 | +365% | No | |
|
|
||||||
| June 23, 2026 filed June 18, 2026 | Berman Howard Director | $0 | 64,400 | 0% | No | |
|
|
||||||
| June 23, 2026 filed June 18, 2026 | KIRSCH ARTHUR S Director | $0 | 64,400 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 8 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free